Perhaps we'll get a status update on CYDY having strarted treating in the clinics this week.
I wonder if the newer understanding of leronlimab's MOA might be influencing this trial even though it has been approved.
(3)
(0)
CytoDyn Inc (CYDY) Stock Research Links
-
-
-
-
-
-
-